Episode 56 with Dr. Gavin Giovannoni, on early phase 3 results of ocrelizumab, the first experimental drug to show some benefit in a progressive form of multiple sclerosis in a major trial
"
Links to articles and other resources mentioned in Episode 56:
- The week's MS-related scientific papers, curated by MSDF
- MSDF Drug-Development Pipeline
- Gavin Giovannoni MBBCH PhD
- Barts MS Blog
- Full Transcript
DOI:
doi/10.7493/msdf.10.27628.1